Pregnancy

PubMed Free Full Text

Medications in pregnancy

Australia

• Australian Journal of General Practice
  • Critical caveats in using product information/pregnancy categories for pregnant or breastfeeding patients [2018]

• Department of Health and Aged Care
  • Prescribing medicines in pregnancy database

Australia, New Zealand

• Royal Australian and New Zealand College of Obstetricians and Gynaecologists
  • Diethylstilboestrol (DES) exposure in utero [2021]

Brazil

• PLoS Neglected Tropical Diseases
  • The organization, weaknesses, and challenges of the control of thalidomide in Brazil: A review [2020]

Cameroon

• BMC Pregnancy and Childbirth
  • First trimester medication use in pregnancy in Cameroon: a multi-hospital survey [2018]

Canada

• Canadian Family Physician
  • Safety of tacrolimus in pregnancy [2014]
  • FDA pregnancy risk categories and the CPS: Do they help or are they a hindrance? [2010]

Denmark

• Journal of the National Cancer Institute
  • Medication-Associated Phthalate Exposure and Childhood Cancer Incidence [2022]

Developed countries

• Pharmacoepidemiology and Drug Safety
  • Prescription drug use during pregnancy in developed countries: a systematic review [2011]

Ethiopia

• SAGE Open Medicine
  • Prescription drugs use during pregnancy in Ethiopia: A systematic review and meta-analysis [2020]

Europe

• EUROmediCAT
  • EUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associations [2016]
  • EUROmediCAT signal detection: a systematic method for identifying potential teratogenic medication [2016]
  • Improving Information on Maternal Medication Use by Linking Prescription Data to Congenital Anomaly Registers: A EUROmediCAT Study [2015]
  • EUROmediCAT Recommendations for European Pharmacovigilance concerning safety of medication use in pregnancy [2015]

• PLoS ONE
  • An inventory of European data sources to support pharmacoepidemiologic research on neurodevelopmental outcomes in children following medication exposure in pregnancy: A contribution from the ConcePTION project [2022]

Europe, United States

• Clinical Pharmacology & Therapeutics
  • Assuring Access to Safe Medicines in Pregnancy and Breastfeeding [2021]

France

• Drug Safety
  • Dispensing of Potentially Harmful Prescription Drugs in 1.8 Million Pregnant Women in France: A Nationwide Study Based on Two Risk Classification Systems [2021]

• International Journal of Environmental Research and Public Health
  • Birth Outcomes in DES Children and Grandchildren: A Multigenerational National Cohort Study on Informative Families [2023]

International

• BMC Pregnancy and Childbirth
  • Interventions to enhance medication adherence in pregnancy- a systematic review [2023]

• BMJ Open
  • Prevalence of polypharmacy in pregnancy: a systematic review [2023]

• Journal of Family & Reproductive Health
  • Knowledge, Information Sources, and Institutional Trust of Patients Regarding Medication Use in Pregnancy: A Systematic Review [2021]

• Seminars in Perinatology
  • Epidemiology of Medications Use in Pregnancy [2015]

Italy

• Annali dell'Istituto Superiore di Sanità
  • Medication prescriptions before, during and after pregnancy in Italy: a population-based study [2021]

• Frontiers in Pharmacology
  • The Italian Network for Monitoring Medication Use During Pregnancy (MoM-Net): Experience and Perspectives [2021]

• International Journal of Environmental Research and Public Health
  • Drug Prescriptions among Italian and Immigrant Pregnant Women Resident in Italy: A Cross-Sectional Population-Based Study [2022]

Japan

• Global Health & Medicine
  • The advances in dealing with the safety of medicated drugs in pregnancy [2021]

Middle East

• Oman Medical Journal
  • Herbal Medicines Use During Pregnancy: A Review from the Middle East [2015]

Netherlands

• British Journal of General Practice
  • GPs' awareness of pregnancy: trends and association with hazardous medication use [2023]

New Zealand

• PLoS ONE
  • Patterns of prescription medicine dispensing before and during pregnancy in New Zealand, 2005–2015 [2020]

Norway

• BMJ Open
  • Longitudinal changes in neurodevelopmental outcomes between 18 and 36 months in children with prenatal triptan exposure: findings from the Norwegian Mother and Child Cohort Study [2016]

Republic of Korea

• PLoS Medicine
  • Neonatal and maternal adverse outcomes and exposure to nonsteroidal anti-inflammatory drugs during early pregnancy in South Korea: A nationwide cohort study [2023]

Sub-Saharan Africa

• Inquiry
  • Traditional Medicine Utilisation Among Pregnant Women in Sub-saharan African Countries: A Systematic Review of Literature [2022]

Suriname

• Advances in Pharmacoepidemiology and Drug Safety
  • Prevalence and safety of prescription medicine use during pregnancy in the Republic of Suriname in the year 2017: a pharmacoepidemiological analysis [2021]

Sweden

• Clinical Epidemiology
  • Drug use during pregnancy in Sweden – assessed by the Prescribed Drug Register and the Medical Birth Register [2011]

Switzerland

• International Journal of Environmental Research and Public Health
  • Use of Prescribed Drugs to Treat Chronic Diseases during Pregnancy in Outpatient Care in Switzerland between 2014 and 2018: Descriptive Analysis of Swiss Health Care Claims Data [2022]

• Swiss Medical Weekly
  • Queries on medication use during pregnancy: characterisation of the Swiss Teratogen Information Service database [2022]
  • Use of drugs to treat symptoms and acute conditions during pregnancy in outpatient care in Switzerland between 2014 and 2018: analysis of Swiss healthcare claims data [2021]

United Kingdom

• BMJ Open
  • Women's experiences of over-the-counter and prescription medication during pregnancy in the UK: findings from survey free-text responses and narrative interviews [2023]

• Medicines and Healthcare products Regulatory Agency
  • Medicines with teratogenic potential: what is effective contraception and how often is pregnancy testing needed? [2019]

• Royal College of Obstetricians and Gynaecologists
  • Developing New Pharmaceutical Treatments for Obstetric Conditions [2015]

• UKTIS
  • UKTIS

United States

• American Journal of Obstetrics & Gynecology
  • Hydroxychloroquine early in pregnancy and risk of birth defects [2021]

• American Journal of Perinatology
  • Improving Safe and Effective Use of Drugs in Pregnancy and Lactation: Workshop Summary [2017]

• American Journal of Transplantation
  • Mycophenolate Fetal Toxicity and Risk Evaluation and Mitigation Strategies [2013]

• Birth Defects Research
  • Use of vasoactive medications in pregnancy and the risk of stillbirth among birth defect cases [2022]
  • Maternal exposure to hydroxychloroquine and birth defects [2021]

• Centers for Disease Control and Prevention
  • Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention—convened meeting [2014]
  • Medicine and Pregnancy

• Expert Review of Clinical Pharmacology
  • The Need for Safer Medication Use in Pregnancy [2013]

• Food and Drug Administration
  • Pregnancy and Lactation Labeling (Drugs) Final Rule [2014]

• JAMA Network Open
  • Evaluation of Drug Labels Following the 2015 Pregnancy and Lactation Labeling Rule [2020]

• Pharmacy and Therapeutics
  • The New Pregnancy and Lactation Labeling Rule [2016]

• PLoS Medicine
  • Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: A population-based cohort study nested in the US Medicaid Analytic eXtract dataset [2020]

• Society for Maternal-Fetal Medicine
  • Prenatal acetaminophen use and outcomes in children [2017]

WHO

• World Health Organization
  • Guidelines for establishing a poison centre [2021]

WHO Eastern Mediterranean Region

• Pharmaceutical Biology
  • Prevalence, motivation, and associated factors of medicinal herbs consumption in pregnant women from Eastern Mediterranean Regional Office: a systematic review [2023]

{Related topics}

• Topic
  • Obstetrics, perinatology
  • Medications and breastfeeding